Lowry Martin, Zelhof Bashar, Liney Gary P, Gibbs Peter, Pickles Martin D, Turnbull Lindsay W
Centre for Magnetic Resonance Investigations, University of Hull, Hull, United Kingdom.
Invest Radiol. 2009 Sep;44(9):577-84. doi: 10.1097/RLI.0b013e3181b4c1fe.
The ability to detect and identify malignant lesions within the prostate with conventional T2-weighted imaging is still limited. Although lesion conspicuity is improved with dynamic contrast-enhanced imaging there still remains some ambiguity as all tissues within the prostate may enhance. The aim of the current study was to take advantage of the improved signal-to-noise ratio at 3 T and assess the ability of 2 alternative pharmacokinetic models to clearly identify malignant areas within the prostate. We also aspire to assess the impact of tissue heterogeneity on variation in estimated pharmacokinetic parameters.
Quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the prostate was implemented using multiple flip angles for T1 determination, and a rapid dynamic 3D T1-weighted acquisition with parallel imaging and a temporal resolution of 6.7 s. Pharmacokinetic analysis was performed for regions of tumor, normal-appearing peripheral zone (PZ), and central gland (CG) using fast exchange limit (FXL) or fast exchange regimen (FXR) models. Cell density was obtained from hematoxylin and eosin stained whole mount radical prostatectomy specimens.
Native tissue T1 was significantly lower in tumor and PZ tissue than in CG. The FXL model revealed increased mean K(trans), k(ep), and v(e) in tumor and CG compared with PZ. With the FXR model, fitting was improved and all parameters were significantly increased, however, there were no longer significant differences between regions for v(e). The additional parameter of the FXR model, tau(i), nominally representing mean lifetime of intracellular water, was significantly decreased in tumor compared with both PZ and CG. Rate constants for CG were significantly lower than those of tumor for both models. In addition, for all tissues, K(trans) and v(e) were positively correlated with cell density.
Accounting for a finite water exchange rate between cells and their environment improves the discrimination of malignant from benign tissues within the prostate and may aid staging accuracy and ability to monitor response to treatment.
利用传统T2加权成像检测和识别前列腺内恶性病变的能力仍然有限。尽管动态对比增强成像提高了病变的显影度,但由于前列腺内所有组织都可能强化,仍存在一些模糊性。本研究的目的是利用3T时改善的信噪比,评估两种替代药代动力学模型清晰识别前列腺内恶性区域的能力。我们还希望评估组织异质性对估计药代动力学参数变化的影响。
采用多个翻转角进行T1测定,并行成像且时间分辨率为6.7秒的快速动态3D T1加权采集,对前列腺进行定量动态对比增强磁共振成像(DCE-MRI)。使用快速交换极限(FXL)或快速交换方案(FXR)模型对肿瘤、外观正常的外周带(PZ)和中央腺体(CG)区域进行药代动力学分析。通过苏木精和伊红染色的前列腺根治性切除标本全切片获得细胞密度。
肿瘤和PZ组织的天然组织T1显著低于CG。与PZ相比,FXL模型显示肿瘤和CG中的平均Ktrans、 kep和ve增加。对于FXR模型,拟合得到改善,所有参数均显著增加,然而,ve在各区域之间不再有显著差异。FXR模型的附加参数tau(i)名义上代表细胞内水的平均寿命,与PZ和CG相比,肿瘤中的该参数显著降低。两种模型中CG的速率常数均显著低于肿瘤。此外,对于所有组织,Ktrans和ve与细胞密度呈正相关。
考虑细胞与其环境之间有限的水交换率可提高前列腺内恶性组织与良性组织的鉴别能力,并可能有助于分期准确性和监测治疗反应的能力。